Fundraising Fox

Sinotau

Beijing, CN · 1 known investors

Find your way into Sinotau

Sinotau develops radiopharmaceutical products, including diagnostic imaging agents for early detection of Alzheimer's disease. The company operates in the radiopharmaceutical sector in China, serving medical institutions and hospitals.

BiotechDigital HealthHealthtechMedical Devices

Investors · 1

Qiming Venture PartnersBeijing · $5M – $134M

In the news

Sinotau aims to become Hong Kong’s ‘first nuclear-medicine stock’ - Bamboo Works - China stock insights for global investorsthebambooworks.com · Jun 2025Sinotau Aims To Be Hong Kong's 'First Nuclear-medicine Stock'sahmcapital.com · Jun 2025China VC Weekly: Flying Cars and More - Pandailypandaily.com · Oct 2021Sinotau Pharmaceutical Group Completes $50 Million D+ Round of Financing with Focus on Radiopharmaceutical R&D - Pandailypandaily.com · Oct 2021Sinotau Pharmaceutical Technology Raises CNY 320 Mn in Series D | EqualOceanequalocean.com · Feb 2021

Frequently asked questions

What does Sinotau do?
Sinotau develops radiopharmaceutical products, including diagnostic imaging agents for early detection of Alzheimer's disease. The company operates in the radiopharmaceutical sector in China, serving medical institutions and hospitals.
Who are Sinotau's investors?
Sinotau's investors include Qiming Venture Partners.
Where is Sinotau headquartered?
Sinotau is headquartered in Beijing, CN.